BERKELEY, CA (UroToday.com) - Superficial bladder cancer is often treated by combining transurethral resection of the tumor with the instillation of antitumor agents or bacillus Calmette-Guérin (BCG), and BCG instillation is promising treatment preventing the recurrence or progression of carcinoma in situ (CIS) and high-grade superficial bladder tumor.To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.